ArticleRSC advances2019

Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway.

Cong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.